Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager

Ascendis Pharma A/S

NASDAQ:ASND

Watchlist

Dividends

Price: 137.62 USD 0.91%

Market Cap: 8.2B USD

Have any thoughts about
Ascendis Pharma A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 137.62 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ASND Alert

Ascendis Pharma A/S

137.62

+1.24 (+0.91%)

52 Week Range	112.93 159.4
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Ascendis Pharma A/S

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Ascendis Pharma A/S.

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Summarize the latest earnings call
of Ascendis Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ascendis Pharma A/S.

Provide P/S
for Ascendis Pharma A/S.

Provide P/E
for Ascendis Pharma A/S.

Provide P/OCF
for Ascendis Pharma A/S.

Provide P/FCFE
for Ascendis Pharma A/S.

Provide P/B
for Ascendis Pharma A/S.

Provide EV/S
for Ascendis Pharma A/S.

Provide EV/GP
for Ascendis Pharma A/S.

Provide EV/EBITDA
for Ascendis Pharma A/S.

Provide EV/EBIT
for Ascendis Pharma A/S.

Provide EV/OCF
for Ascendis Pharma A/S.

Provide EV/FCFF
for Ascendis Pharma A/S.

Provide EV/IC
for Ascendis Pharma A/S.

Show me price targets
for Ascendis Pharma A/S made by professional analysts.

What are the Revenue projections
for Ascendis Pharma A/S?

How accurate were the past Revenue estimates
for Ascendis Pharma A/S?

What are the Net Income projections
for Ascendis Pharma A/S?

How accurate were the past Net Income estimates
for Ascendis Pharma A/S?

What are the EPS projections
for Ascendis Pharma A/S?

How accurate were the past EPS estimates
for Ascendis Pharma A/S?

What are the EBIT projections
for Ascendis Pharma A/S?

How accurate were the past EBIT estimates
for Ascendis Pharma A/S?

Compare the revenue forecasts
for Ascendis Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ascendis Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ascendis Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ascendis Pharma A/S compared to its peers.

Compare the P/E ratios
of Ascendis Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Ascendis Pharma A/S with its peers.

Analyze the financial leverage
of Ascendis Pharma A/S compared to its main competitors.

Show all profitability ratios
for Ascendis Pharma A/S.

Provide ROE
for Ascendis Pharma A/S.

Provide ROA
for Ascendis Pharma A/S.

Provide ROIC
for Ascendis Pharma A/S.

Provide ROCE
for Ascendis Pharma A/S.

Provide Gross Margin
for Ascendis Pharma A/S.

Provide Operating Margin
for Ascendis Pharma A/S.

Provide Net Margin
for Ascendis Pharma A/S.

Provide FCF Margin
for Ascendis Pharma A/S.

Show all solvency ratios
for Ascendis Pharma A/S.

Provide D/E Ratio
for Ascendis Pharma A/S.

Provide D/A Ratio
for Ascendis Pharma A/S.

Provide Interest Coverage Ratio
for Ascendis Pharma A/S.

Provide Altman Z-Score Ratio
for Ascendis Pharma A/S.

Provide Quick Ratio
for Ascendis Pharma A/S.

Provide Current Ratio
for Ascendis Pharma A/S.

Provide Cash Ratio
for Ascendis Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Ascendis Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Ascendis Pharma A/S?

What is the current Free Cash Flow
of Ascendis Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ascendis Pharma A/S.

P/E
Price to Earnings

-18.8

Current

-13.7

Median

22.1

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

-18.8

Market Cap

8.3B USD

Net Income

-426.5m EUR

All Countries

Forward Multiples

			Market Cap	P/E
DK		Ascendis Pharma A/S NASDAQ:ASND	8.3B USD	-18.8
FR		Pharnext SCA OTC:PNEXF	6T USD	-180 740.1
US		Abbvie Inc NYSE:ABBV	310.2B USD	61
US		Amgen Inc NASDAQ:AMGN	142B USD	33.4
US		Gilead Sciences Inc NASDAQ:GILD	115B USD	910
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	101.6B USD	-211.2
US	E	Epizyme Inc F:EPE	94.1B EUR	-472.7
AU		CSL Ltd ASX:CSL	134.4B AUD	31.8
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	78.5B USD	16.8
US	S	Seagen Inc F:SGT	39.3B EUR	-54.7
NL		argenx SE XBRU:ARGX	36B EUR	-135.6

				Earnings Growth	P/E to Growth
DK		Ascendis Pharma A/S NASDAQ:ASND	Average P/E: 210.6 Negative Multiple: -18.8	N/A	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -180 740.1	N/A	N/A
US		Abbvie Inc NYSE:ABBV	61	413%	0.1
US		Amgen Inc NASDAQ:AMGN	33.4	73%	0.5
US		Gilead Sciences Inc NASDAQ:GILD	910	77%	11.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -211.2	48%	N/A
US	E	Epizyme Inc F:EPE	Negative Multiple: -472.7	N/A	N/A
AU		CSL Ltd ASX:CSL	31.8	65%	0.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	16.8	44%	0.4
US	S	Seagen Inc F:SGT	Negative Multiple: -54.7	N/A	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -135.6	N/A	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

-17.9

2-Years Forward

P/E

-31.2

3-Years Forward

P/E

-800.3

	Franklin Covey Co NYSE:FC	36.26 USD -0.41%
	Mohawk Industries Inc NYSE:MHK	119.01 USD -0.13%
	Ardmore Shipping Corp NYSE:ASC	11.71 USD 3.54%
	ASGN Inc NYSE:ASGN	83.295 USD -0.69%
	Skyworks Solutions Inc NASDAQ:SWKS	89.24 USD 0.55%
	Weatherford International PLC NASDAQ:WFRD	68.08 USD 1.46%

	Johnson & Johnson NYSE:JNJ	143.8502 USD -0.43%
	Bank of America Corp NYSE:BAC	43.52 USD -1.47%
	Mastercard Inc NYSE:MA	522.55 USD -1.04%
	Salesforce Inc NYSE:CRM	339.66 USD -1.16%
	Abbvie Inc NYSE:ABBV	175.38 USD -0.11%
	Home Depot Inc NYSE:HD	389.12 USD -0.89%

	Arista Networks Inc NYSE:ANET	112.88 USD 0.06%
	Visa Inc NYSE:V	314.05 USD -1.15%
	Texas Pacific Land Corp NYSE:TPL	1 111.54 USD -1.9%
	KLA Corp NASDAQ:KLAC	636.62 USD 1.15%
	Manhattan Associates Inc NASDAQ:MANH	276.005 USD -1.52%
	Pinduoduo Inc NASDAQ:PDD	99.31 USD -0.2%

	Salesforce Inc NYSE:CRM	339.66 USD -1.16%
	Accenture PLC NYSE:ACN	356.66 USD -2.65%
	ServiceNow Inc NYSE:NOW	1 082.78 USD -0.78%
	EOG Resources Inc NYSE:EOG	118.98 USD -0.05%
	Copart Inc NASDAQ:CPRT	58.06 USD -0.27%
	Applied Materials Inc NASDAQ:AMAT	165.535 USD 1.19%

Ascendis Pharma A/S
NASDAQ:ASND

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Ascendis Pharma A/S NASDAQ:ASND

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Ascendis Pharma A/S
NASDAQ:ASND

P/E
Price to Earnings